AC Immune up 10% premarket on Q2 results

AC Immune (ACIU) Q2 results (CHF): Revenues: 1.5M (-25.0%).

Net loss: (16.9M) (-52.3%); loss/share: (0.24) (2-6.3%); Non-GAAP Net loss: (15.5M) (-43.5%); Non-GAAP loss/share: (0.22) (-15.8%).

Shares are up 10% premarket.

Previously: AC Immune reports Q2 results (Aug. 14)

https://seekingalpha.com/news/3491649-ac-immune-10-percent-premarket-q2-results